Table 3.

Comparison of clinical factors between 4F2hc Low and 4F2hc High groups.

	4F2hc Low	4F2hc High	P
Age (y)	64.50 ± 5.25	66.50 ± 5.20	0.0162	*
cT stage (n)			0.0255	*
1	29	25
2	5	8
3	2	9
GS (n)			0.0035	*
6	17	7
7	19	18
8	3	9
9	1	8
TST (ng/dL)	4.66 ± 1.92	4.64 ± 1.78	0.1661
PSA (ng/mL)	7.46 ± 6.37	8.30 ± 6.57	0.3781
PSAD	0.27 ± 0.23	0.30 ± 0.31	0.1156

Data are expressed as means ± standard deviation unless otherwise indicated. cT stage = clinical tumour stage, GS = Gleason score, TST = testosterone, PSA = prostate-specific antigen, PSAD = PSA density.

*Statistical significance (p < 0.05).